Aqueous two-phase systems comprising ionic liquids for the extraction of recombinant proteins

The progress made on the use of new biopharmaceuticals has a high influence on the global health, and since the approval of humulin (recombinant insulin) by FDA, new protein-based pharmaceuticals have been introduced in the market such as the interferon alfa 2b (IFNα2b), which has been used in in th...

ver descrição completa

Detalhes bibliográficos
Autor principal: Castro, Leonor S. (author)
Outros Autores: Almeida, Mafalda R. (author), Pereira, Patrícia (author), Passarinha, Luís (author), Sousa, Fani (author), Coutinho, João (author), Tavares, Ana P. M. (author), Freire, Mara G. (author), Pedro, Augusto (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2020
Assuntos:
ATPS
Ionic liquids
Biopharmaceuticals
Recombinant protein
Texto completo:http://hdl.handle.net/10773/28741
País:Portugal
Oai:oai:ria.ua.pt:10773/28741

Texto Completo

http://hdl.handle.net/10773/28741

Registros relacionados